• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 485564 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413926020 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413926020 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Sell Off Shares of Ariad Pharmaceuticals, Down 3.4%

Published on Wed, 04/24/2013 - 10:21
By Robert Cotter

Ariad Pharmaceuticals (NASDAQ:ARIA) is one of today's biggest movers, down 3.4% to $17.97. The Dow Jones Industrial Average is now trading fractionally lower to 14,714 and the S&P is trading fractionally higher to 1,581.

Ariad Pharmaceuticals has overhead space with shares priced $17.97, or 36.2% below the average consensus analyst price target of $28.19. Ariad Pharmaceuticals shares should first meet resistance at the 50-day moving average (MA) of $19.67 and find additional resistance at the 200-day MA of $20.59.

ARIAD Pharmaceuticals, Inc. discovers and develops breakthrough medicines that regulate cell signaling with small molecules. The Company is primarily focused on product candidates for targeted indications. ARIAD is developing products to treat solid tumors, to block the spread of cancer, to treat certain forms of leukemia, and to treat cancer that has spread to bone and primary bone cancers.

Over the past year, Ariad Pharmaceuticals has traded in a range of $14.78 to $25.40 and is now at $17.97, 22% above that low. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.4%.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Rentrak Looks to Continue to Trade Above...

Rentrak (NASDAQ:RENT) traded at a new 52-week high today of $76.50. So far today appro ...

Watch for Continued Gains in Shares of O...

Shares of O'Reilly Automotive (NASDAQ:ORLY) traded today at $158.93, breaking its 52-we ...

Netease.com: The Winning Streak Continue...

Netease.com (NASDAQ:NTES) traded at a new 52-week high today of $94.97. This new high ...

Watch for Continued Gains in Shares of N...

Shares of Nautilus (NYSE:NLS) traded at a new 52-week high today of $13.41. This new h ...

Watch for Continued Gains in Shares of M...

Micron Technology (NASDAQ:MU) traded at a new 52-week high today of $30.93. This new h ...

Monster Worldwide Looks to Continue to T...

Monster Worldwide (NASDAQ:MNST) traded today at a new 52-week high of $99.05. So far t ...

Watch for Continued Gains in Shares of L...

Landstar System (NASDAQ:LSTR) traded at a new 52-week high today of $74.02. So far tod ...

Shares of Kilroy Realty Rise to a New 52...

Shares of Kilroy Realty (NYSE:KRC) traded at a new 52-week high today of $64.36. This ...